Year: 2024
Type: article
Abstract: Questions and Answers on VaccinationAt the last meeting of the World Health Organization Strategic Advisory Group of Experts on Immunization (SAGE) on 23-26 September 2024, given the global burden of severe lower respiratory tract infection due to respiratory syncytial virus (RSV), it was recommended that all countries introduce passive immunization to prevent RSV disease in early infancy.SAGE also emphasized that RSV is a major cause of morbidity and mortality in older adults.This article provides short answers to some frequently asked questions about RSV vaccines and monoclonal antibodies against RSV.
DOI: 10.5578/ced.20240410
Authors: Aslıhan Coşkun, Ateş Kara
Institution: Hacettepe University
Language: English
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
OpenAlex ID: W4405420717